Your browser is no longer supported. Please, upgrade your browser.
Settings
GWPH GW Pharmaceuticals plc daily Stock Chart
GWPH [NASD]
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-8.63 Insider Own0.04% Shs Outstand26.97M Perf Week5.00%
Market Cap4.27B Forward P/E- EPS next Y-5.14 Insider Trans0.00% Shs Float2.04M Perf Month16.42%
Income-220.40M PEG- EPS next Q-2.67 Inst Own80.90% Short Float75.88% Perf Quarter34.92%
Sales16.10M P/S265.04 EPS this Y-84.20% Inst Trans-5.11% Short Ratio3.84 Perf Half Y37.86%
Book/sh24.79 P/B6.38 EPS next Y59.20% ROA- Target Price155.50 Perf Year46.77%
Cash/sh17.38 P/C9.10 EPS next 5Y- ROE- 52W Range92.65 - 160.54 Perf YTD19.85%
Dividend- P/FCF- EPS past 5Y- ROI-46.80% 52W High-1.45% Beta2.63
Dividend %- Quick Ratio- Sales past 5Y-24.30% Gross Margin68.90% 52W Low70.77% ATR6.05
Employees586 Current Ratio- Sales Q/Q50.00% Oper. Margin- RSI (14)74.15 Volatility3.99% 3.67%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.91 Prev Close151.81
ShortableYes LT Debt/Eq- EarningsMay 08 AMC Payout- Avg Volume401.82K Price158.22
Recom2.30 SMA2010.23% SMA5022.27% SMA20031.11% Volume373,257 Change4.22%
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Sep-26-16Reiterated Cantor Fitzgerald Buy $165 → $182
Aug-26-16Upgrade Numis Sell → Hold
Aug-09-16Reiterated Cantor Fitzgerald Buy $181 → $165
Jun-03-16Initiated Cantor Fitzgerald Buy $181
Mar-03-16Initiated Numis Sell
Feb-18-16Reiterated Leerink Partners Outperform $129 → $100
Nov-30-15Initiated ROTH Capital Buy $130
Aug-13-15Initiated Morgan Stanley Overweight $150
Apr-14-15Reiterated Leerink Partners Outperform $102 → $120
May-08-14Reiterated Canaccord Genuity Buy $65 → $102
May-23-18 12:54PM  Here's Why The Marijuana ETF Could Be A Short-Covering Idea Benzinga
06:02AM  This Latest Marijuana Survey Should Be Great News for Cannabis-Focused Biotechs Motley Fool
May-21-18 01:20PM  Trade Talks, Micron's Guidance, & Marijuana Stock Charts | Free Lunch Zacks
07:15AM  Bristol-Myers Squibb and Three Additional Stocks Under Scanner in the Drug Makers Space ACCESSWIRE
May-20-18 07:30PM  5 Marijuana Stocks To Watch In 2018 Oilprice.com
01:11PM  This Cannabis-Based Drug Is On the Verge of Making History Motley Fool
07:21AM  Are Oregon's Marijuana Woes a Precursor of What's to Come in Canada? Motley Fool
May-17-18 10:00AM  Cannabis Investors Buzzing Over Canada's Green Organic Dutchman IPO TheStreet.com
08:28AM  This Marijuana Stock's Bulls Need a Reality Check Motley Fool
08:27AM  Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More Benzinga
06:30AM  5 Things You'll Want to Know About What Could Be the Biggest Medical Marijuana Drug Ever Motley Fool
May-16-18 05:28PM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Cannabidiol Oral Solution in Lennox-Gastaut Syndrome GlobeNewswire
05:00PM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Epidiolex® (cannabidiol oral solution) in Lennox-Gastaut Syndrome GlobeNewswire
05:00PM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Cannabidiol Oral Solution in Lennox-Gastaut Syndrome GlobeNewswire
09:24AM  Market Morning Roundup: Amazon Fumes, Medical Cannabis to Follow Sports Betting? Market Exclusive
May-14-18 05:51PM  Edited Transcript of GWPH.O earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
08:21AM  Despite Losing $88 Million in Q2, This Pot Stock Still Has More Cash Than Any of Its Peers Motley Fool
May-10-18 07:06AM  Alcohol, Tobacco and Pharma Investing in Pot as Hedge: Moody's Investopedia
May-09-18 06:02AM  The Only 2 Numbers in This Top Marijuana Stock's Q2 Results That Matter Motley Fool
May-08-18 06:00PM  GW Pharmaceuticals Stock Slides on Q2 Earnings Miss InvestorPlace
05:37PM  GW Pharmaceuticals (GWPH) Stock Moving Higher After Posting Q2 Earnings Zacks
04:00PM  GW Pharmaceuticals plc Reports Fiscal Second Quarter 2018 Financial Results and Operational Progress GlobeNewswire
02:05PM  Why Marijuana Stock GW Pharmaceuticals Gained 18% in April Motley Fool
01:00PM  GW Pharmaceuticals to Present at Bank of America Merrill Lynch 2018 Health Care Conference GlobeNewswire
May-07-18 03:26PM  3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement InvestorPlace
02:49PM  Don't Expect Joints If the FDA Ever Approves Medical Marijuana Bloomberg
May-06-18 06:06PM  Better Marijuana Stock: Canopy Growth vs. GW Pharmaceuticals Motley Fool
May-04-18 08:59AM  What's in Store for Prothena (PRTA) This Earnings Season? Zacks
08:21AM  A Major Marijuana Milestone Is Less Than 2 Months Away Motley Fool
May-03-18 07:37AM  GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018 GlobeNewswire
May-01-18 10:35AM  GW Pharma (GWPH) Q2 Earnings: Is a Turnaround in the Cards? Zacks
Apr-30-18 02:59PM  A Promising Step for Medical Marijuana Motley Fool
Apr-29-18 05:14PM  You'll Never Guess What Jeff Sessions Just Said About Marijuana Motley Fool
Apr-28-18 11:41AM  Has Support for Legal Marijuana Plateaued? Motley Fool
05:57AM  Cannabis Industry Sits on Precipice of Major Expansion TheStreet.com
Apr-27-18 09:48AM  Can Jafaki Help Incyte (INCY) Beat Earnings Estimates in Q1? Zacks
Apr-26-18 06:40PM  A Promising Step for Medical Marijuana Motley Fool
Apr-25-18 02:03PM  What to expect from marijuana stocks after the first big medical cannabis win MarketWatch
12:50PM  Epilepsy Drug Fuels Cannabis-Stock Buzz Barrons.com
Apr-23-18 05:36PM  What Lies Ahead for Vice ETFs? Zacks
10:15AM  Heres Why The Committee News Is So Important For GW Pharmaceuticals Market Exclusive
Apr-22-18 09:36AM  The Only 4 States That Completely Ban THC and CBD Motley Fool
06:31AM  The Simple Reason Why Marijuana Stock Valuations Aren't as Sky-High as They Seem Motley Fool
Apr-20-18 01:36PM  Why legalized marijuana is giving opportunity to women entrepreneurs Yahoo Finance Video
09:55AM  Philip Morris International Inc. Stock Went Up in Smoke Go Long InvestorPlace
09:09AM  The Market In 5 Minutes: Oil, Amazon, GW Pharma And More Benzinga
08:21AM  20 Marijuana Facts for 4/20 Motley Fool
06:55AM  FDA Close to Approving First Cannabis-Based Drug Investopedia
Apr-19-18 04:41PM  FDA Panel Backs Cannabis-Based Drug For Childhood Seizures Investor's Business Daily
03:20PM  FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy Forbes
02:44PM  Cannabis based plant approved for epilepsy treatment CNBC Videos
02:24PM  GW Pharma gets FDA panel nod, first cannabis-based drug nearing approval Reuters
01:23PM  What Stocks are on the Marijuana Index? Investopedia
01:06PM  US experts back marijuana-based drug for childhood seizures Associated Press
01:05PM  [$$] FDA Panel Backs Proposed Epilepsy Drug Derived From Cannabis The Wall Street Journal
12:55PM  GW Pharma wins unanimous recommendation from FDA advisory committee for cannabis-derived drug MarketWatch
12:45PM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announces the Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epilepsy GlobeNewswire
12:43PM  Cannabis-derived drug clears hurdle on way to FDA approval CNBC
12:10PM  A Drug Made from Cannabis Moves Closer to Approval in a U.S. First Bloomberg
11:44AM  FDA panel unanimously votes for GW Pharma's cannabis-derived epilepsy drug Reuters
10:10AM  3 Marijuana Stock Charts That Are Simply Smokin InvestorPlace
08:25AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
08:21AM  3 "Marijuana Firsts" You Should Expect in 2018 Motley Fool
Apr-18-18 02:57PM  Want to Buy Marijuana Stocks? Check Out These 3 Charts Zacks
08:30AM  Todays Research Reports on Trending Tickers: GW Pharmaceuticals and Arena Pharmaceuticals ACCESSWIRE
Apr-17-18 04:29PM  GW Pharma Spikes On Growing Likelihood FDA Will OK Cannabis-Based Med Investor's Business Daily +11.24%
02:15PM  Marijuana-based drug gets positive review from US agency Associated Press
02:08PM  Why This Huge Marijuana Stock Is Soaring 10% Today Motley Fool
01:52PM  Why GW Pharmaceuticals Stock Is Soaring Today InvestorPlace
12:20PM  Can Cannabis Treat Seizures? Biotechs Say The Answer Is Yes Investor's Business Daily
11:41AM  GW Pharmaceuticals plc (NASDAQ:GWPH): Are Analysts Optimistic? Simply Wall St.
11:03AM  GW Pharma shares surge on FDA briefing document that hints at approval of cannabis-derived drug MarketWatch
08:55AM  Drug Made From Cannabis Plant Gets Backing From FDA Staff Bloomberg
Apr-15-18 09:07AM  Investors Are Betting Big Against This Marijuana Stock -- Are They Wrong? Motley Fool
Apr-13-18 09:20AM  Is Cannabis The Answer To Seizures? These Biotechs Say Yes Investor's Business Daily
Apr-12-18 07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Magic Software Enterprises, Tuniu, Visteon, Magna International, Eaton Corporation, and GW Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
07:00AM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting GlobeNewswire
Apr-06-18 05:41PM  Marijuana Stock Charts: How 3 Pot Plays Performed in Volatile Markets Zacks
Apr-04-18 07:30AM  Here's Why The Mayo Clinic Owns 10% of This Unknown Epilepsy Stock with Big Upcoming FDA Catalyst ACCESSWIRE
Apr-02-18 12:31PM  On World Autism Awareness Day, A Look At Biotech Firms With Potential Treatments In The Pipeline Benzinga -6.04%
Mar-28-18 06:04AM  3 Biotechs That Could Get Big Boosts in April Motley Fool
Mar-26-18 07:47AM  3 Blockbuster Drug Launches to Watch In 2018 Motley Fool
Mar-22-18 06:49PM  Cramer's lightning round: Marijuana stock GW Pharmaceuticals is too hot to buy CNBC
Mar-20-18 06:34AM  Why Didn't Investors Care About This Marijuana Stock's Big News? Motley Fool
Mar-16-18 07:45PM  Is This the Next "Big Thing" in Marijuana? Motley Fool
08:20AM  Report: Developing Opportunities within Capital Product Partners, Adient, Arbutus Biopharma, GW Pharmaceuticals, Customers, and Laureate Education Future Expectations, Projections Moving into 2018 GlobeNewswire
Mar-15-18 09:06AM  Zacks Market Edge Highlights: Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties and AbbVie Zacks
Mar-14-18 11:06AM  The Best Marijuana Stocks Right Now Zacks
Mar-13-18 04:01PM  GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents GlobeNewswire
12:53PM  Why GW Pharmaceuticals Stock Lost 17.7% in February Motley Fool
Mar-11-18 11:41AM  Is There a Link Between Marijuana Use and Kidney Disease? The Shocking Answer Motley Fool
Mar-07-18 05:00AM  America Is Giving Away the $30 Billion Medical Marijuana Industry Bloomberg
Mar-06-18 03:00PM  Why Zogenix Inc. Shares Shot Up 16.6% in February Motley Fool
Mar-05-18 12:36PM  GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March GlobeNewswire
Mar-03-18 11:40AM  Opinion: Rescheduling Marijuana Would Make Things Even Worse Than They Are Now Motley Fool
Mar-02-18 03:38PM  Pot Stocks, ETFs And Top News From The Cannabis Industry This Week Benzinga
Mar-01-18 08:10AM  Todays Research Reports on Stocks to Watch: Cronos and GW Pharmaceuticals ACCESSWIRE
Feb-28-18 08:21AM  This Marijuana Stock Is the Perfect Middleman for Pot Enthusiasts and Opponents Motley Fool
Feb-27-18 07:00AM  GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis GlobeNewswire
Feb-25-18 08:09PM  Four Marijuana Stocks to Buy Now Insider Monkey
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates, which are in Phase I and II clinical development for the treatment of glioma, neonatal hypoxic-ischemic encephalopathy, adult epilepsy, and schizophrenia. Further, the company has license and development agreements with Otsuka Pharmaceutical Co. Ltd.; Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.